Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction

Journal of Lower Genital Tract Disease

Volumn 16, Issue 4, 2012, Pages 471-479

  Gargano, Julia W ^a,b   Wilkinson, Edward J ^c   Unger, Elizabeth R ^b   Steinau, Martin ^b   Watson, Meg ^d   Huang, Youjie ^e   Copeland, Glenn ^f   Cozen, Wendy ^g   Goodman, Marc T ^h   Hopenhayn, Claudia ⁱ   Lynch, Charles F ^j   Hernandez, Brenda Y ^h   Peters, Edward S ^k   Saber, Maria Sibug ^g   Lyu, Christopher W ^l   Sands, Lauren A ^b   Saraiya, Mona ^e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^e FLORIDA DEPARTMENT OF HEALTH   (United States)

^f MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h UNIVERSITY OF HAWAII CANCER CENTER   (United States)

ⁱ UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^j UNIVERSITY OF IOWA   (United States)

^k LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^l BATTELLE MEMORIAL INSTITUTE   (United States)

more..

Author keywords

cancer registry; human papillomavirus; vaccine; vulvar cancers; vulvar intraepithelial neoplasia

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER REGISTRY; FEMALE; HISTOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; HYBRIDIZATION; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; SQUAMOUS CELL CARCINOMA; UNITED STATES; VAGINAL INTRAEPITHELIAL NEOPLASIA; VIRUS DETECTION; VULVA CANCER; VULVA INTRAEPITHELIAL NEOPLASIA 3; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; DNA, VIRAL; FEMALE; GENOTYPE; HISTOCYTOCHEMISTRY; HUMANS; MICROSCOPY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; UNITED STATES; VIRAL STRUCTURAL PROTEINS; VULVAR NEOPLASMS;

EID: 84867572404     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e3182472947     Document Type: Article

References (28)

1. U.S. Cancer Statistics Working Group. United States Cancer Statistics (USCS) 1999-2007: incidence and mortalitY web-based report. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2010. Available at: www.cdc.gov/uscs. Accessed April 25, 2011.
2. SaraiYa M,Watson M,Wu X, king JB, ChenVW, Smith JS, et al. Incidence of in situ and invasive vulvar cancer in the US, 1998-2003. Cancer 2008;113:2865-72.
3. Watson M, SaraiYa M, Wu X. Update of HPVassociated female genital cancers in the United States, 1999- 2004. J Womens Health (Larchmt) 2009;18:1731-8.
4. Madeleine MM, Daling JR. Cancers of the vulva and vagina. In: Schottenfeld D, Fraumeni JF, eds. Cancer EpidemiologY and Prevention. New York: Oxford UniversitY Press; 2006:1068-74.
5. Kurman R, Ronnett J, Sherman M, Wilkinson E. Atlas of Tumor PathologY: Tumors of the Cervix, Vagina, and Vulva. Washington, DC: American RegistrY of PathologY; 2010.
6. Srodon M, Stoler MH, Baber GB, Kurman RJ. The distribution of low and high-risk HPV tYpes in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN). Am J Surg Pathol 2006;30:1513-8.
7. Heller DS, van Seters M, Marchitelli C, MoYal- Barracco M, Preti M, van Beurden M. Update on intraepithelial neoplasia of the vulva: proceedings of a workshop at the 2009World Congress of the International SocietY for the StudY of Vulvovaginal Diseases, Edinburgh, Scotland, September 2009. J Lower Gen Tract Dis 2010;14:363-73.
8. De VuYst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and tYpe distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analYsis. Int J Cancer 2009; 124:1626-36.
9. International AgencY for Research on Cancer. Human papillomaviruses. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. LYons, France: International AgencY for Research on Cancer; 2007;1-636.
10. Insinga RP, Liaw KL, Johnson LG, Madeleine MM. A sYstematic review of the prevalence and attribution of human papillomavirus tYpes among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev 2008;17:1611-22.
11. Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM. Human papillomavirus tYpe-distribution in vulvar and vaginal cancers and their associated precursors. Obstet GYnecol 2009;113:917-24.
12. Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, Wheeler CM, et al. EfficacY of a prophYlactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus tYpes 16 and 18 in Young women: an interim analYsis of a phase III double-blind, randomised controlled trial. Lancet 2007;369:2161-70.
13. Villa LL, Costa RL, Petta CA, Andrade RP, Paavonen J, Iversen OE, et al. High sustained efficacY of a prophYlactic quadrivalent human papillomavirus tYpes 6/11/16/18 L1 virus-like particle vaccine through 5 Years of follow-up. Br J Cancer 2006;95:1459-66.
14. Sideri M, Jones RW, Wilkinson EJ, Preti M, Heller DS, ScurrY J, et al. Squamous vulvar intraepithelial neoplasia: 2004 modified terminologY, ISSVD Vulvar OncologY Subcommittee. J Reprod Med 2005;50:807-10.
15. Steinau M, Patel SS, Unger ER. Efficient DNA extraction for HPV genotYping in formalin-fixed, paraffin-embedded tissues. J Mol Diagn 2011;13:377-81.
16. OnYekwuluje JM, Steinau M, Swan DC, Unger ER. A real time PCR assaY for HPV52 detection and viral load quantification. Clin Lab. In press.
17. Carter JJ, Madeleine MM, Shera K, Schwartz SM, Cushing-Haugen KL, Wipf GC, et al. Human papillomavirus 16 and 18 L1 serologY compared across anogenital cancer sites. Cancer Res 2001;61:1934-40.
18. Haefner HK, Tate JE, McLachlin CM, Crum CP. Vulvar intraepithelial neoplasia: age, morphological phenotYpe, papillomavirus DNA, and coexisting invasive carcinoma. Hum Pathol 1995;26:147-54.
19. Hampl M, Sarajuuri H, Wentzensen N, Bender HG, Kueppers V. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstet GYnecol 2006;108:1361-8.
20. Kim YT, Thomas NF, Kessis TD, Wilkinson EJ, Hedrick L, Cho KR. p53 mutations and clonalitY in vulvar carcinomas and squamous hYperplasias: evidence suggesting that squamous hYperplasias do not serve as direct precursors of human papillomavirusYnegative vulvar carcinomas. Hum Pathol 1996;27:389-95.
21. Monk BJ, Burger RA, Lin F, Parham G, Vasilev SA, WilczYnski SP. Prognostic significance of human papillomavirus DNA in vulvar carcinoma. Obstet GYnecol 1995;85:709-15.
22. Pinto AP, Signorello LB, Crum CP, Harlow BL, Abrao F, Villa LL. Squamous cell carcinoma of the vulva in Brazil: prognostic importance of host and viral variables. GYnecol Oncol 1999;74:61-7.
23. Sutton BC, Allen RA, Moore WE, Dunn ST. Distribution of human papillomavirus genotYpes in invasive squamous carcinoma of the vulva. Mod Pathol 2008;21:345-54.
24. Ueda -, Enomoto T, Kimura T, Yoshino K, Fujita M. Two distinct pathwaYs to development of squamous cell carcinoma of the vulva. J Skin Cancer 2011;2011:951250.
25. van de Nieuwenhof HP, van Kempen LC, de Hullu JA, Bekkers RL, Bulten J, Melchers WJ, et al. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned. Cancer Epidemiol Biomarkers Prev 2009;18:2061-7.
26. Tan SE, Garland SM, Rumbold AR, Tabrizi SN. Human papillomavirus genotYping using archival vulval dYsplastic or neoplastic biopsY tissues: comparison between the INNO-LiPA and linear arraY assaYs. J Clin Microbiol 2010;48: 1458-60.
27. Thoburn KK, German RR, Lewis M, Nichols PJ, Ahmed F, Jackson-Thompson J. Case completeness and data accuracY in the Centers for Disease Control and Prevention's National Program of Cancer Registries. Cancer 2007;109: 1607-16.
28. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813-9.